Ocean Biomedical, Inc. Operating Income Loss

Quick Answer

Ocean Biomedical, Inc. reported Operating Income Loss of -$3.80 million for the year ending 2024.

  • Ocean Biomedical, Inc. showed an increase of +62.8% in Operating Income Loss from 2023 to 2024.
  • This data is from Ocean Biomedical, Inc.'s annual report (Form 10-K), filed with the SEC on April 8, 2025.
  • XBRL data for this metric is available from 2022 to 2024 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2022 to 2024), Ocean Biomedical, Inc.'s Operating Income Loss has grown by 76.4%.
  • Historical annual values: Fiscal year 2024: -$3.80 million | Fiscal year 2023: -$10.21 million | Fiscal year 2022: -$16.12 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: